Halper Sadeh LLC is investigating whether shareholders of Supernus Pharmaceuticals, Integer Holdings, and Bowhead Specialty Holdings received fair deals in their recent sales. The law firm is concerned that insiders may have gained financial benefits not available to ordinary shareholders and that deal terms could limit better competing offers. Shareholders are encouraged to contact Halper Sadeh LLC for free legal consultation to explore their rights and options. The firm may seek increased compensation or other relief on behalf of shareholders if wrongdoing is found.
Dianthus Therapeutics announced inducement grants of stock options to six newly hired non-executive employees. The grants total 87,000 options with a 10-year term and an exercise price of $106.02 per share, vesting over four years. These grants were ...
Nasdaq has notified NusaTrip Incorporated that its securities will be delisted from the Nasdaq Stock Market on August 12, 2026, unless the company appeals. Trading in NusaTrip shares has been halted since October 23, 2025, following a suspension by t...
Nasdaq has notified Magnitude International Ltd. that its securities will be delisted from the Nasdaq Stock Market on August 12, 2026, unless the company appeals the decision. Trading in the company's shares has been halted since December 19, 2025, f...
Robinson Helicopter Company introduced its new R88 helicopter at LABACE 2026 in São Paulo, Brazil, marking its first appearance in South America. The R88 is a versatile, multi-mission helicopter designed to fill the gap between light single-engine an...
Stocks in the defense, pharmaceutical, and industrial sectors saw significant gains driven by strong operational results and strategic acquisitions. T3 Defense Inc. surged 122.18% after reporting record revenue and new orders, boosting investor confi...
